Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 3/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL9314976 | 0.97 | F2 (0.41) | ALOX15CA1CA2MMP1MMP2 | |
| Ethylenediamine SCHEMBL10684380 | 0.92 | CYP1A2 (0.39) | ALOX15CA1CA2MMP1MMP2 | |
| SCHEMBL9766397 | 0.87 | ALDH1A1 (0.46) | ALOX15CA1CA2MMP1MMP2 | |
| SCHEMBL7284889 | 0.83 | F2 (0.48) | ALOX15CA1CA2MMP1MMP2 | |
| SCHEMBL28861367 | 0.79 | ALDH1A1 (0.40) | ALOX15CA1CA2MMP1MMP2 | |
| SCHEMBL11651045 | 0.79 | MMP2 (0.50) | ALOX15MMP2ALDH1A1HSD17B10TSHR | |
| SCHEMBL28244595 | 0.79 | PRNP (0.42) | ALOX15CA1CA2MMP1MMP2 | |
| SCHEMBL28057527 | 0.79 | ALB (0.50) | ALOX15ALDH1A1HSD17B10MAPK1KDM4E | |
| SCHEMBL29032363 | 0.77 | MAPK1 (0.45) | ALOX15CA1CA2MMP1MMP2 | |
| SCHEMBL1308246 | 0.77 | ALDH1A1 (0.38) | ALOX15CA1CA2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102523-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | JUBILANT DRAXIMAGE INC (CA) | 2026-04-16 | — | — | US | claimed |
| US-12440583-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | JUBILANT DRAXIMAGE, INC. (CA) | 2025-10-14 | — | — | US | claimed |
| EP-3592735-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF | JUBILANT GENERICS LTD FORMERLY A DIVISION OF JUBILANT LIFE SCIENCES LTD (IN) | 2024-03-20 | — | — | EP | claimed |
| US-20240050598-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-02-15 | — | — | US | claimed |
| US-11857647-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | JUBILANT DRAXIMAGE, INC. | 2024-01-02 | — | — | US | claimed |
| CN-116059409-A | Novel technetium-99 m therapeutic diagnostic agent for cardiac radiography and ventricular evaluation and evaluation method | 程毓渡 | 2023-05-05 | — | — | CN | claimed |
| CN-114940553-A | Unipolar and bipolar electric control ion exchange reactor and group | 中联西北工程设计研究院有限公司 | 2022-08-26 | — | — | CN | claimed |
| EP-1085984-B1 | I INKJET RECEPTOR MEDIA AND COATING SOLUTIONS THEREFOR | MINNESOTA MINING & MFG (US) | 2005-12-28 | — | — | EP | claimed |
| US-6383612-B1 | PIGMENT METAL SALT COATING IMPREGNATED INTO POROUS MEMBRANE; AROMATIC OR ALIPHATIC DRYING AGENT WITH SULFONIC, CARBOXYLIC, PHENOLIC, AND/OR HYDROXYL FUNCTIONAL GROUPS; WATERPROOFING, COLORFASTNESS, NONSMEARING | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-07 | — | — | US | claimed |
| EP-1085984-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2001-03-28 | — | — | EP | claimed |
| WO-1999065702-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-12-23 | — | — | WO | claimed |
| US-20260102523-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | JUBILANT DRAXIMAGE INC (CA) | 2026-04-16 | — | — | US | disclosed |
| US-12440583-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | JUBILANT DRAXIMAGE, INC. (CA) | 2025-10-14 | — | — | US | disclosed |
| US-20250299889-A1 | SOLID ELECTROLYTIC CAPACITOR ELEMENT AND SOLID ELECTROLYTIC CAPACITOR | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250104928-A1 | ELECTROLYTIC CAPACITOR AND METHOD OF MANUFACTURING SAME | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-03-27 | — | — | US | disclosed |
| WO-2003064166-A1 | RECEPTOR MEDIUM HAVING A MICROFIBRILLATED SURFACE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-08-07 | — | — | WO | disclosed |
| US-6383612-B1 | PIGMENT METAL SALT COATING IMPREGNATED INTO POROUS MEMBRANE; AROMATIC OR ALIPHATIC DRYING AGENT WITH SULFONIC, CARBOXYLIC, PHENOLIC, AND/OR HYDROXYL FUNCTIONAL GROUPS; WATERPROOFING, COLORFASTNESS, NONSMEARING | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-07 | — | — | US | disclosed |
| EP-1085984-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999065702-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-12-23 | — | — | WO | disclosed |
| US-4331788-A | ACTIVATION WITH SOLUBLE METAL COMPLEX AND NITRIC ACID | CHLOE CHIMIE (FR) | 1982-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11857647-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | TREH, TYMP, PRCP | ALOX15 4873/4885CA1 1233/4885CA2 1719/4885 |
| US-20260102523-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | TREH, CD68, THPO | ALOX15 3850/4885CA1 52/4885CA2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.